Similar articles

• Human placental lactogen (HPL) levels in abnormal pregnancies.

  Lindberg BS, Nilsson BA. Lindberg BS, et al. J Obstet Gynaecol Br Commonw. 1973 Dec;80(12):1046-53. doi: 10.1111/j.1471-0528.1973.tb02978.x. J Obstet Gynaecol Br Commonw. 1973. PMID: 4202566 No abstract available.
• [Human placental lactogen in endangered pregnancy].

  Schmitt R, Roll H, Hepp H, Schneller H. Schmitt R, et al. Z Geburtshilfe Perinatol. 1973 Apr;177(2):118-28. Z Geburtshilfe Perinatol. 1973. PMID: 4198069 German. No abstract available.
• Clinical and pathologic evaluation of serum immunoreactive human placental lactogen (IR-HPL) in abnormal pregnancy.

  Varma K, Driscoll SG, Emerson K Jr, Selenkow HA. Varma K, et al. Obstet Gynecol. 1971 Oct;38(4):487-99. doi: 10.1097/00006250-197110000-00001. Obstet Gynecol. 1971. PMID: 4999733 No abstract available.
• Progesterone and pregnanediol.

  Keller PJ. Keller PJ. Contrib Gynecol Obstet. 1976;2:75-91. Contrib Gynecol Obstet. 1976. PMID: 802080 Review. No abstract available.
• Human placental lactogen in the monitoring of high-risk pregnancy.

  Chard T. Chard T. Ric Clin Lab. 1982 Jan-Mar;12(1):207-20. doi: 10.1007/BF02909328. Ric Clin Lab. 1982. PMID: 6806885 Review. No abstract available.